These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 25808906

  • 1. Staging of cognitive deficits and neuropathological and ultrastructural changes in streptozotocin-induced rat model of Alzheimer's disease.
    Knezovic A, Osmanovic-Barilar J, Curlin M, Hof PR, Simic G, Riederer P, Salkovic-Petrisic M.
    J Neural Transm (Vienna); 2015 Apr; 122(4):577-92. PubMed ID: 25808906
    [Abstract] [Full Text] [Related]

  • 2. The effect of NAD-299 and TCB-2 on learning and memory, hippocampal BDNF levels and amyloid plaques in Streptozotocin-induced memory deficits in male rats.
    Afshar S, Shahidi S, Rohani AH, Komaki A, Asl SS.
    Psychopharmacology (Berl); 2018 Oct; 235(10):2809-2822. PubMed ID: 30027497
    [Abstract] [Full Text] [Related]

  • 3. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J, Madhunapantula SV, Chinni S, Khatwal RB, Dubala A, Muthureddy Nataraj SK, Basavan D.
    Behav Brain Res; 2014 Jul 01; 267():55-65. PubMed ID: 24667360
    [Abstract] [Full Text] [Related]

  • 4. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S.
    J Alzheimers Dis; 2010 Jul 01; 19(2):691-704. PubMed ID: 20110613
    [Abstract] [Full Text] [Related]

  • 5. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study.
    Salkovic-Petrisic M, Osmanovic-Barilar J, Brückner MK, Hoyer S, Arendt T, Riederer P.
    J Neural Transm (Vienna); 2011 May 01; 118(5):765-72. PubMed ID: 21533606
    [Abstract] [Full Text] [Related]

  • 6. Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer's disease.
    Barilar JO, Knezovic A, Grünblatt E, Riederer P, Salkovic-Petrisic M.
    J Neural Transm (Vienna); 2015 Apr 01; 122(4):565-76. PubMed ID: 25503661
    [Abstract] [Full Text] [Related]

  • 7. Intracerebroventricular Streptozotocin as a Model of Alzheimer's Disease: Neurochemical and Behavioral Characterization in Mice.
    Ravelli KG, Rosário BD, Camarini R, Hernandes MS, Britto LR.
    Neurotox Res; 2017 Apr 01; 31(3):327-333. PubMed ID: 27913964
    [Abstract] [Full Text] [Related]

  • 8. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
    Park SJ, Kim YH, Nam GH, Choe SH, Lee SR, Kim SU, Kim JS, Sim BW, Song BS, Jeong KJ, Lee Y, Park YI, Lee KM, Huh JW, Chang KT.
    Int J Mol Sci; 2015 Jan 22; 16(2):2386-402. PubMed ID: 25622254
    [Abstract] [Full Text] [Related]

  • 9. Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.
    Salkovic-Petrisic M, Knezovic A, Osmanovic-Barilar J, Smailovic U, Trkulja V, Riederer P, Amit T, Mandel S, Youdim MB.
    Life Sci; 2015 Sep 01; 136():108-19. PubMed ID: 26159898
    [Abstract] [Full Text] [Related]

  • 10. Streptozotocin-induced hippocampal astrogliosis and insulin signaling malfunction as experimental scales for subclinical sporadic Alzheimer model.
    Rostami F, Javan M, Moghimi A, Haddad-Mashadrizeh A, Fereidoni M.
    Life Sci; 2017 Nov 01; 188():172-185. PubMed ID: 28867578
    [Abstract] [Full Text] [Related]

  • 11. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats.
    Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H.
    Neurol Sci; 2014 May 01; 35(5):741-51. PubMed ID: 24337945
    [Abstract] [Full Text] [Related]

  • 12. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
    Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F.
    Brain Res; 2009 Jul 24; 1281():117-27. PubMed ID: 19374888
    [Abstract] [Full Text] [Related]

  • 13. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A, Xu X, Bi X, Baudry M.
    J Alzheimers Dis; 2012 Jul 24; 30(1):183-208. PubMed ID: 22406441
    [Abstract] [Full Text] [Related]

  • 14. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
    Zhang H, Wang D, Gong P, Lin A, Zhang Y, Ye RD, Yu Y.
    J Alzheimers Dis; 2019 Jul 24; 67(1):169-179. PubMed ID: 30475772
    [Abstract] [Full Text] [Related]

  • 15. Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer's Disease.
    Gupta S, Yadav K, Mantri SS, Singhal NK, Ganesh S, Sandhir R.
    Mol Neurobiol; 2018 Dec 24; 55(12):8916-8935. PubMed ID: 29611103
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of intracranial islet grafting on cognitive functioning in a rat metabolic model of sporadic Alzheimer's disease-like dementia.
    Bloch K, Hornfeld SH, Dar S, Vanichkin A, Gil-Ad I, Vardi P, Weizman A.
    PLoS One; 2020 Dec 24; 15(1):e0227879. PubMed ID: 31929603
    [Abstract] [Full Text] [Related]

  • 17. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse).
    Chen Y, Liang Z, Blanchard J, Dai CL, Sun S, Lee MH, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.
    Mol Neurobiol; 2013 Apr 24; 47(2):711-25. PubMed ID: 23150171
    [Abstract] [Full Text] [Related]

  • 18. Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease.
    Bloch K, Gil-Ad I, Vanichkin A, Hornfeld SH, Taler M, Dar S, Azarov D, Vardi P, Weizman A.
    J Alzheimers Dis; 2018 Apr 24; 65(4):1445-1458. PubMed ID: 30175977
    [Abstract] [Full Text] [Related]

  • 19. Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer's disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis.
    Saleh SR, Abd-Elmegied A, Aly Madhy S, Khattab SN, Sheta E, Elnozahy FY, Mehanna RA, Ghareeb DA, Abd-Elmonem NM.
    Int J Pharm; 2024 Jun 10; 658():124218. PubMed ID: 38734273
    [Abstract] [Full Text] [Related]

  • 20. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Liu C, Wu Y, Zha S, Liu M, Wang Y, Yang G, Ma K, Fei Y, Zhang Y, Hu X, Yang W, Qian Y.
    Brain Res; 2016 Jan 15; 1631():137-46. PubMed ID: 26656068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.